Tags: Drug.

Nilotinib (AMN107 trade name Tasigna) in the form of the hydrochloride monohydrate salt is a small molecule tyrosine kinase inhibitor approved for the treatment of imatinib-resistant chronic myelogenous leukemia.

Nilotinib2DACS.svg
ATC prefix
L01
ATC suffix
XE08
Bioavailability
30.0
CAS number
641571-10-0(base)
ChEBI
52172
DrugBank
DB04868
FDA UNII code
F41401512X
IUPAC name
4-methyl-N-[3-(4-methyl-1H-imidazol-1-yl)- 5-(trifluoromethyl)phenyl]-3- [(4-pyridin-3-ylpyrimidin-2-yl) amino]benzamide
PubChem
644241

Loading...

This page contains content from the copyrighted Wikipedia article "Nilotinib"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.